Clinical Course of Neurologic Adverse Events Associated With Immune Checkpoint Inhibitors: Focus on Chronic Toxicities.
Simone RossiAntonio FarinaAntonio MalvasoAlessandro DinotoLaura FiondaSara CornacchiniIrene FloreanLuigi ZulianiMatteo GaribaldiAntonio LaulettaFlavia BaccariCorrado ZenesiniRita RinaldiSara MariottoValentina DamatoLuca DiamantiMatteo GastaldiAlberto VogrigEnrico MarchioniMaria GuarinoPublished in: Neurology(R) neuroimmunology & neuroinflammation (2024)
More than half of the patients with n-irAEs who survived the acute phase developed a chronic condition. Patients with chronic n-irAEs were at higher risk of death, mainly due to cancer progression. Future studies are needed to further characterize chronic n-irAEs and identify optimal long-term management strategies.